SPEXIS AG, a clinical-stage biopharmaceutical company, announced that its CXCR4 inhibitor balixafortide demonstrated synergistic efficacy in combination with docetaxel compared to either drug alone...
Unilabs, the leading diagnostic services provider, announced a partnership with Subtle Medical, a healthcare technology company using artificial intelligence for faster and higher quality...
Azra AI's proprietary software — which uses artificial intelligence (AI) and natural language processing to identify incidental lung nodules in medical reports — is...
Industry leader with substantial U.S. and global experience in drug development and medical affairs joins Lyra as the Company's late-stage product candidates advance in the...
The Company's first product, iCapture™45, is pending FDA clearance. Several clinical trials will commence in the USA and Israel within a few weeks, in addition to an ongoing clinical...
